Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function.
Saved in:
| Title: | Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function. |
|---|---|
| Authors: | Sinclair JE; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Vedelago C; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, Australia., Ryan FJ; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; College of Medicine and Public Health and Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Carney M; School of Mathematics and Physics, University of Queensland, Brisbane, Queensland, Australia., Redd MA; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Lynn MA; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; College of Medicine and Public Health and Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Grubor-Bauk B; Viral Immunology Group, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia., Cao Y; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Henders AK; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Chew KY; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia., Gilroy D; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Greaves K; Sunshine Coast University Hospital, Queensland Health, Birtinya, Queensland, Australia.; National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia., Labzin L; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Ziser L; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Ronacher K; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia.; Mater Research Institute - The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Wallace LM; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Zhang Y; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, Australia., Macauslane K; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia., Ellis DJ; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia., Rao S; Gene Regulation and Translational Medicine Laboratory, Department of Infection and Inflammation, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Burr L; Mater Research Institute, The University of Queensland, South Brisbane, Queensland, Australia.; Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia., Bain A; Gene Regulation and Translational Medicine Laboratory, Department of Infection and Inflammation, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Karawita A; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, Victoria, Australia., Schulz BL; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia., Li J; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, Australia., Lynn DJ; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; College of Medicine and Public Health and Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Palpant N; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Wuethrich A; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, Australia., Trau M; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, Australia., Short KR; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia. k.short@uq.edu.au.; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, Queensland, Australia. k.short@uq.edu.au.; Queensland Immunology Research Centre, The University of Queensland, St Lucia, Queensland, Australia. k.short@uq.edu.au. |
| Source: | Nature microbiology [Nat Microbiol] 2024 Dec; Vol. 9 (12), pp. 3135-3147. Date of Electronic Publication: 2024 Oct 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101674869 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2058-5276 (Electronic) Linking ISSN: 20585276 NLM ISO Abbreviation: Nat Microbiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
